[Requirements regarding compounded pharmaceutical preparation].
Picking the wrong container with raw material in making compounded pharmaceutical preparation is one of the threats to patient safety. The question is whether there still is a place for this type of medication in pharmacotherapy. This case raises three questions: is there a therapeutic rationale for this therapeutic agent, how far should we go in individualizing pharmacotherapy and what are the pharmaceutical prerequisites for this kind of compounding? Once there is an agreement about the need for this product, the focus is on the need for implementation of Good Manufacturing Practice (GMP) rules in community pharmacies. Alternatively, this type of individualized therapy should be stopped.